Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
JYSB2500055	司美格鲁肽注射液	semaglutide	Injection	Biological Products	Supplementary Application	2025-03-04	Novo Nordisk Pharma AG;Novo Nordisk A/S	view
JYSB2500054	司美格鲁肽注射液	semaglutide	Injection	Biological Products	Supplementary Application	2025-03-04	Novo Nordisk Pharma AG;Novo Nordisk A/S	view
JYSB2500016	司美格鲁肽注射液	semaglutide	Injection	Biological Products	Supplementary Application	2025-01-10	Novo Nordisk A/S	view
JYSB2500015	司美格鲁肽注射液	semaglutide	Injection	Biological Products	Supplementary Application	2025-01-10	Novo Nordisk A/S	view
JYSB2500014	司美格鲁肽注射液	semaglutide	Injection	Biological Products	Supplementary Application	2025-01-10	Novo Nordisk A/S	view
JYSB2500013	司美格鲁肽注射液	semaglutide	Injection	Biological Products	Supplementary Application	2025-01-10	Novo Nordisk A/S	view
JYSB2500012	司美格鲁肽注射液	semaglutide	Injection	Biological Products	Supplementary Application	2025-01-10	Novo Nordisk A/S	view
JYSB2400227	司美格鲁肽注射液	semaglutide	Injection	Biological Products	Supplementary Application	2024-10-17	Novo Nordisk A/S	view
JYSB2400226	司美格鲁肽注射液	semaglutide	Injection	Biological Products	Supplementary Application	2024-10-17	Novo Nordisk A/S	view
JYSB2400225	司美格鲁肽注射液	semaglutide	Injection	Biological Products	Supplementary Application	2024-10-17	Novo Nordisk A/S	view
JYSB2400224	司美格鲁肽注射液	semaglutide	Injection	Biological Products	Supplementary Application	2024-10-17	Novo Nordisk A/S	view
JYSB2400223	司美格鲁肽注射液	semaglutide	Injection	Biological Products	Supplementary Application	2024-10-17	Novo Nordisk A/S	view
JYSB2400188	司美格鲁肽注射液	semaglutide	Injection	Biological Products	Supplementary Application	2024-08-23	Novo Nordisk Pharma AG;Novo Nordisk A/S	view
JYSB2400187	司美格鲁肽注射液	semaglutide	Injection	Biological Products	Supplementary Application	2024-08-23	Novo Nordisk Pharma AG;Novo Nordisk A/S	view
JYSB2400150	司美格鲁肽注射液	semaglutide	Injection	Biological Products	Supplementary Application	2024-07-12	Novo Nordisk Pharma AG;Novo Nordisk A/S	view
JYSB2400149	司美格鲁肽注射液	semaglutide	Injection	Biological Products	Supplementary Application	2024-07-12	Novo Nordisk Pharma AG;Novo Nordisk A/S	view
JYSB2300171	司美格鲁肽注射液	semaglutide	Injection	Biological Products	Supplementary Application	2023-10-09	Novo Nordisk Pharma AG;Novo Nordisk A/S	view
JYSB2300170	司美格鲁肽注射液	semaglutide	Injection	Biological Products	Supplementary Application	2023-10-09	Novo Nordisk Pharma AG;Novo Nordisk A/S	view
JYSB2300040	司美格鲁肽注射液	semaglutide	Injection	Biological Products(3.1)	Supplementary Application	2023-02-23	Novo Nordisk Pharma AG;Novo Nordisk A/S	view
JYSB2300039	司美格鲁肽注射液	semaglutide	Injection	Biological Products(3.1)	Supplementary Application	2023-02-23	Novo Nordisk Pharma AG;Novo Nordisk A/S	view